Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com 9 November 2026 Section 708A Cleansing Statement This notice is given by Neurizon Therapeutics Limited ACN 094 006 023 (ASX: NUZ) (Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). The Company...
Section 708A Cleansing Statement
Filed with ASX · · 2 pages · English
Release
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Application for quotation of securities - NUZ
- Investor webinar reminder and presentation
- Notification of cessation of securities - NUZ
- Withdrawal of Resolution 4 from Notice of AGM
- Redemption of all remaining Obsidian convertible notes
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics